Cyprinid herpesvirus II (CyHV-2) is highly contagious and pathogenic to Carassius auratus gibelio (gibel carp)， causing enormous economic losses in aquaculture in Yancheng city， Jiangsu province， China; however， to date， there is no effective way to protect C. auratus gibelio from CyHV-2 infection. In this study， a recombinant baculovirus vector vaccine， BacCarassius-D4ORFs， containing a fused codon-optimized sequence D4ORFs comprising the ORF72 (region 1-186 nt)， ORF66 (region 993-1197 nt)， ORF81 (region 603-783 nt) and ORF82 (region 85-186 nt) genes of CyHV-2， driven by a Megalobrama amblycephala β-actin promoter， was constructed. Then， qPCR， Western blotting and immunoflu... More
Cyprinid herpesvirus II (CyHV-2) is highly contagious and pathogenic to Carassius auratus gibelio (gibel carp)， causing enormous economic losses in aquaculture in Yancheng city， Jiangsu province， China; however， to date， there is no effective way to protect C. auratus gibelio from CyHV-2 infection. In this study， a recombinant baculovirus vector vaccine， BacCarassius-D4ORFs， containing a fused codon-optimized sequence D4ORFs comprising the ORF72 (region 1-186 nt)， ORF66 (region 993-1197 nt)， ORF81 (region 603-783 nt) and ORF82 (region 85-186 nt) genes of CyHV-2， driven by a Megalobrama amblycephala β-actin promoter， was constructed. Then， qPCR， Western blotting and immunofluorescence assays showed that the fused gene D4ORFs was successfully delivered and expressed in fish cells or tissues by transduction with BacCarassius-D4ORFs. The fused gene D4ORFs could not be detected by PCR in the C. auratus gibelio injected with BacCarassius-D4ORFs after 7 weeks. Specific antibody against ORF72 could be detected in the serum of vaccinated C. auratus gibelio by injection with BacCarassius-D4ORFs. Furthermore， when C. auratus gibelio were vaccinated with BacCarassius-D4ORFs via the oral or injection route， followed by challenge with CyHV-2， the relative survival rate of immunized C. auratus gibelio reached 59.3% and 80.01%， respectively. These results suggested that BacCarassius-D4ORFs has the potential to be used as a vector-based vaccine for the prevention and treatment of disease caused by CyHV-2 infection.
